BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

781 related articles for article (PubMed ID: 10985706)

  • 21. Racial and ethnic differences in the treatment and outcome of cardiogenic shock following acute myocardial infarction.
    Palmeri ST; Lowe AM; Sleeper LA; Saucedo JF; Desvigne-Nickens P; Hochman JS;
    Am J Cardiol; 2005 Oct; 96(8):1042-9. PubMed ID: 16214435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Echocardiographic and angiographic correlations in patients with cardiogenic shock secondary to acute myocardial infarction.
    Berkowitz MJ; Picard MH; Harkness S; Sanborn TA; Hochman JS; Slater JN
    Am J Cardiol; 2006 Oct; 98(8):1004-8. PubMed ID: 17027560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interhospital transfer for early revascularization in patients with ST-elevation myocardial infarction complicated by cardiogenic shock--a report from the SHould we revascularize Occluded Coronaries for cardiogenic shocK? (SHOCK) trial and registry.
    Jeger RV; Tseng CH; Hochman JS; Bates ER
    Am Heart J; 2006 Oct; 152(4):686-92. PubMed ID: 16996836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial.
    French JK; Feldman HA; Assmann SF; Sanborn T; Palmeri ST; Miller D; Boland J; Buller CE; Steingart R; Sleeper LA; Hochman JS;
    Am Heart J; 2003 Nov; 146(5):804-10. PubMed ID: 14597928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry.
    Jacobs AK; Leopold JA; Bates E; Mendes LA; Sleeper LA; White H; Davidoff R; Boland J; Modur S; Forman R; Hochman JS
    J Am Coll Cardiol; 2003 Apr; 41(8):1273-9. PubMed ID: 12706920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Culprit lesion location and outcome in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial.
    Fuernau G; Fengler K; Desch S; Eitel I; Neumann FJ; Olbrich HG; de Waha A; de Waha S; Richardt G; Hennersdorf M; Empen K; Hambrecht R; Jung C; Böhm M; Pöss J; Strasser RH; Schneider S; Ouarrak T; Schuler G; Werdan K; Zeymer U; Thiele H
    Clin Res Cardiol; 2016 Dec; 105(12):1030-1041. PubMed ID: 27378612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Smoker's paradox" in patients with cardiogenic shock complicating myocardial infarction - A substudy of the IABP-SHOCK II-trial and registry.
    Saad M; Fuernau G; Desch S; Eitel I; Jung C; Pöss J; Schneider S; Schuler G; Werdan K; Zeymer U; Thiele H
    Int J Cardiol; 2016 Nov; 222():775-779. PubMed ID: 27521557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing practice patterns in the management of acute myocardial infarction complicated by cardiogenic shock: elderly compared with younger patients.
    Dzavík V; Burton JR; Kee C; Teo KK; Ignaszewski A; Lucas AR; Tymchak WJ
    Can J Cardiol; 1998 Jul; 14(7):923-30. PubMed ID: 9706277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial.
    Sanborn TA; Sleeper LA; Webb JG; French JK; Bergman G; Parikh M; Wong SC; Boland J; Pfisterer M; Slater JN; Sharma S; Hochman JS;
    J Am Coll Cardiol; 2003 Oct; 42(8):1373-9. PubMed ID: 14563577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ability to achieve complete revascularization is associated with improved in-hospital survival in cardiogenic shock due to myocardial infarction: Manitoba cardiogenic SHOCK Registry investigators.
    Hussain F; Philipp RK; Ducas RA; Elliott J; Džavík V; Jassal DS; Tam JW; Roberts D; Garber PJ; Ducas J
    Catheter Cardiovasc Interv; 2011 Oct; 78(4):540-8. PubMed ID: 21547996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study.
    Berger PB; Holmes DR; Stebbins AL; Bates ER; Califf RM; Topol EJ
    Circulation; 1997 Jul; 96(1):122-7. PubMed ID: 9236426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intra-aortic balloon counterpulsation and delayed revascularization for myocardial infarction and shock in the absence of primary angioplasty: a treatment strategy with or without thrombolysis?
    Drakos SG; Anastasiou-Nana MI; Terrovitis JV; Tsagalou EP; Kanakakis J; Ntalianis A; Lazaris N; Maroulidis G; Venetsanakos J; Bonios M; Nanas JN
    Coron Artery Dis; 2008 Nov; 19(7):521-6. PubMed ID: 18923249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry.
    Dzavik V; Sleeper LA; Cocke TP; Moscucci M; Saucedo J; Hosat S; Jiang X; Slater J; LeJemtel T; Hochman JS;
    Eur Heart J; 2003 May; 24(9):828-37. PubMed ID: 12727150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock.
    Picard MH; Davidoff R; Sleeper LA; Mendes LA; Thompson CR; Dzavik V; Steingart R; Gin K; White HD; Hochman JS;
    Circulation; 2003 Jan; 107(2):279-84. PubMed ID: 12538428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial.
    Webb JG; Lowe AM; Sanborn TA; White HD; Sleeper LA; Carere RG; Buller CE; Wong SC; Boland J; Dzavik V; Porway M; Pate G; Bergman G; Hochman JS;
    J Am Coll Cardiol; 2003 Oct; 42(8):1380-6. PubMed ID: 14563578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiogenic shock: a summary of the randomized SHOCK trial.
    Menon V; Fincke R
    Congest Heart Fail; 2003; 9(1):35-9. PubMed ID: 12556676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiogenic shock: predictors of outcome based on right and left ventricular size and function at presentation.
    Mendes LA; Picard MH; Sleeper LA; Thompson CR; Jacobs AK; White HD; Hochman JS; Davidoff R
    Coron Artery Dis; 2005 Jun; 16(4):209-15. PubMed ID: 15915072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiogenic shock complicating myocardial infarction and outcome following percutaneous coronary intervention.
    Lee KW; Norell MS
    Acute Card Care; 2008; 10(3):131-43. PubMed ID: 18972627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiogenic shock complicating acute myocardial infarction--a review.
    Dubey L; Sharma S; Gautam M; Gautam S; Guruprasad S; Subramanyam G
    Acta Cardiol; 2011 Dec; 66(6):691-9. PubMed ID: 22299378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiogenic shock.
    Topalian S; Ginsberg F; Parrillo JE
    Crit Care Med; 2008 Jan; 36(1 Suppl):S66-74. PubMed ID: 18158480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.